Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register‐study based on data from the German Childhood Cancer Registry
Open Access
- 9 May 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 153 (4) , 742-755
Abstract
Childhood cancer is the leading disease‐related cause of death among under 15 year olds in Europe. Since primary preventive measures are lacking, improving survival probabilities and long‐term well‐being remain primary goals. With this report, we provide the first long‐term assessment and interpretation of patterns in childhood cancer survival in Germany, covering a period of 30 years. Using data from the German Childhood Cancer Registry, we assessed temporal patterns of cancer survival among children (0‐14 years) diagnosed in Germany from 1991 to 2016, by cancer type, age at diagnosis and sex. We calculated overall survival (OS) and average annual percentage changes of the respective 5‐year OS estimates. OS improved across all cancer types, age groups as well as for boys and girls over time. Five‐year OS for all childhood cancers combined increased from 77.8% in 1991‐1995 to 86.5% in 2011‐2016, with stronger improvements during the early 1990s. The most pronounced survival improvement was seen for acute myeloid leukaemia, at 2% annually and 5‐year OS recently reaching 81.5%. Survival improvements for some diagnoses such as neuroblastoma, renal tumours and bone tumours have flattened out. Tremendous enhancements in diagnostics, treatment and supportive care have affected average survival improvements for most cancer types. Recently, survival improvements have decelerated overall and for some cancer types, it plateaued at an unsatisfactory level. As not all children benefited equally from the survival improvements, personal factors (eg, socioeconomic circumstances, health literacy, access to care) likely affect individual prognosis and warrant further investigation.Keywords
This publication has 59 references indexed in Scilit:
- Survival from childhood cancer in northern England, 1968–2005British Journal of Cancer, 2011
- Disparities in cancer outcomes: Lessons learned from children with cancerPediatric Blood & Cancer, 2011
- Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trialsLeukemia, 2010
- Survival of European children and young adults with cancer diagnosed 1995–2002European Journal of Cancer, 2009
- Methods for Equivalence and Noninferiority TestingTransplantation and Cellular Therapy, 2009
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008
- History of the treatment of childhood ALL: A paradigm for cancer cureBest Practice & Research Clinical Haematology, 2006
- International Classification of Childhood Cancer, third editionCancer, 2005
- The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Blood, 2004
- Obtaining Confidence Intervals for the Risk Ratio in Cohort Studies1978